Clinical Trial Update: Study To Evaluate The Efficacy Of Tofacitinib In Patients With SJS/TEN [NA]

View source ↗

Summary

A completed clinical trial assessed the efficacy of tofacitinib in patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stevens-johnson Syndrome
• Toxic Epidermal Necrolysis

Drugs mentioned

• Tofacitinib (Xeljanz) (tofacitinib)

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis | NA | Status: COMPLETED | Results posted: 2025-09-16